CLINICAL_TRIALS
trial_result
· 2016-08-04
Clinical Trial Update: Ovarian Cancer Vaccine for Patients in Remission [Phase 2]
Summary
Phase 2 trial update for an ovarian cancer vaccine in patients in remission; the study is completed and results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Prima BioMed Ltd | Conditions: Epithelial Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-08-04